Page last updated: 2024-09-05

sb 203580 and salinomycin

sb 203580 has been researched along with salinomycin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(salinomycin)
Trials
(salinomycin)
Recent Studies (post-2010) (salinomycin)
3,48941,13767230409

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)salinomycin (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.24

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, SC; Kim, KY; Kim, SH; Kim, YW; Ma, JY; Park, KI; Park, SG; Seo, YK; Yu, SN1

Other Studies

1 other study(ies) available for sb 203580 and salinomycin

ArticleYear
Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
    International journal of molecular sciences, 2017, May-18, Volume: 18, Issue:5

    Topics: Apoptosis; Autophagy; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Male; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrans; Pyridines; Reactive Oxygen Species; TOR Serine-Threonine Kinases

2017